Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that NVX-CoV2373, its protein-based COVID-19 vaccine, is...
Novartis announced today that the US Food and Drug Administration (FDA) approved Pluvicto™ (lutetium Lu 177 vipivotide tetraxetan) (formerly referred to as 177Lu-PSMA-617) for...
Techcon, part of OK International and Dover, and a leader in precision fluid dispensing technologies, announced the launch of its new TS9800 Series Jet...
MoonLake Immunotherapeutics AG ("MoonLake"), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, announced that it is proceeding with a global...
LogicBio® Therapeutics, Inc. , a clinical-stage genetic medicine company, announced that president and chief executive officer, Frederic Chereau, will present a company overview at...
